Rock Star Mike Peters in Remission from Aggressive Cancer After NHS Trial

The Alarm frontman, diagnosed with Richter's syndrome, credits experimental therapy for his recovery.

Mike Peters, lead singer of The Alarm, is in remission from an aggressive lymphoma following an NHS clinical trial.
Peters was diagnosed with Richter's syndrome, a transformation of chronic lymphocytic leukaemia (CLL) into a more aggressive form, just days before a planned US tour.
The trial at the Christie NHS Foundation Trust in Manchester combined acalabrutinib, a targeted therapy, with standard chemotherapy.
Doctors now aim to find a suitable donor for a stem cell transplant to prevent the leukaemia from returning.
Peters, who has battled cancer for nearly three decades, expressed gratitude for the support from fans and the medical team.